Vaxart (VXRT) has withdrawn its reverse stock split proposal. “After careful consideration, we have decided to officially withdraw our reverse stock split proposal. Moving forward, we will continue to communicate frequently with our stockholders across multiple channels,” said Steven Lo, Chief Executive Officer of Vaxart. “At the same time and more importantly, our team remains intensely focused on advancing the science behind our promising oral pill vaccine platform to create significant long-term value for all our stockholders.”
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VXRT:
- Vaxart Withdraws Proposal, Cancels Stockholder Meeting
- Vaxart shareholders reiterate intent to vote against reverse stock split
- Vaxart shareholders ‘condemn’ board decision to adjourn reverse stock split vote
- Vaxart Adjourns Stockholder Meeting for Vote Solicitation
- Vaxart announces adjournment of special meeting of stockholders